Postmastectomy Radiation Therapy for Node-Negative Breast Cancer of 5 cm or Larger Tumors: A Multicenter Retrospective Analysis (KROG 20-03)
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To evaluate the role of postmastectomy radiation therapy (PMRT) in patients with node-negative breast cancer of 5cm or larger tumors undergoing mastectomy. Materials and methods: Medical records of 274 patients from 18 institutions treated with mastectomy between January 2000 and December 2016 were retrospectively reviewed. Among these, 202 patients underwent PMRT, while 72 did not. Two hundred and forty-one patients (88.0%) received systemic chemotherapy, and 172 (62.8%) received hormonal therapy. Patients receiving PMRT were younger, more likely to have progesterone receptor-positive tumors, and received adjuvant chemotherapy more frequently compared with those without PMRT (p <0.001, 0.018, and <0.001, respectively). Other characteristics were not significantly different between the two groups. Results: With a median follow-up of 95 months (range, 1-249), there were 9 locoregional recurrences, and 20 distant metastases. The 8-year locoregional recurrence-free survival rates were 98.0% with PMRT and 91.3% without PMRT (p=0.133), and the 8-year disease-free survival (DFS) rates were 91.8% with PMRT and 73.9% without PMRT (p=0.008). On multivariate analysis incorporating age, histologic grade, lymphovascular invasion, hormonal therapy, chemotherapy, and PMRT, the absence of lymphovascular invasion and the receipt of PMRT were associated with improved DFS (p=0.025 and 0.009, respectively). Conclusion: Locoregional recurrence rate was very low in node-negative breast cancer of 5cm or larger tumors treated with mastectomy regardless of the receipt of PMRT. However, PMRT was significantly associated with improved DFS. Further investigation is needed to confirm these findings.
Abstract
Purpose: To evaluate the role of postmastectomy radiation therapy (PMRT) in patients with node-negative breast cancer of 5cm or larger tumors undergoing mastectomy. Materials and methods: Medical records of 274 patients from 18 institutions treated with mastectomy between January 2000 and December 2016 were retrospectively reviewed. Among these, 202 patients underwent PMRT, while 72 did not. Two hundred and forty-one patients (88.0%) received systemic chemotherapy, and 172 (62.8%) received hormonal therapy. Patients receiving PMRT were younger, more likely to have progesterone receptor-positive tumors, and received adjuvant chemotherapy more frequently compared with those without PMRT (p <0.001, 0.018, and <0.001, respectively). Other characteristics were not significantly different between the two groups. Results: With a median follow-up of 95 months (range, 1-249), there were 9 locoregional recurrences, and 20 distant metastases. The 8-year locoregional recurrence-free survival rates were 98.0% with PMRT and 91.3% without PMRT (p=0.133), and the 8-year disease-free survival (DFS) rates were 91.8% with PMRT and 73.9% without PMRT (p=0.008). On multivariate analysis incorporating age, histologic grade, lymphovascular invasion, hormonal therapy, chemotherapy, and PMRT, the absence of lymphovascular invasion and the receipt of PMRT were associated with improved DFS (p=0.025 and 0.009, respectively). Conclusion: Locoregional recurrence rate was very low in node-negative breast cancer of 5cm or larger tumors treated with mastectomy regardless of the receipt of PMRT. However, PMRT was significantly associated with improved DFS. Further investigation is needed to confirm these findings.
참고문헌 (18)
- Overgaard M, "Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial", N Engl J Med, 337, pp.949~955 (1997)
- Overgaard M, "Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamo-xifen : Danish Breast Cancer Cooperative Group DBCG 82c randomised trial", Lancet, 353, pp.1641~1648 (1999)
- "Breast cancer (version 6.2020)"[URL]
- Clarke M, "Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival : an overview of the randomised trials", Lancet, 366, pp.2087~2106 (2005)
- EBCTCG (Early Breast Cancer Trialists’ Collaborative Group), "Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality : meta-analysis of individual patient data for 8135 women in 22 randomised trials", Lancet, 383, pp.2127~2135 (2014)
- Johnson ME, "Postmastectomy radiation therapy for T3N0 : a SEER analysis", Cancer, 120, pp.3569~3574 (2014)
- Francis SR, "Outcomes and utilization of postmastectomy radiotherapy for T3N0 breast cancers", Breast, 32, pp.156~161 (2017)
- Almahariq MF, "Post-mastectomy radiotherapy is associated with improved overall survival in T3N0 patients who do not receive chemotherapy", Radiother Oncol, 145, pp.229~237 (2020)
- Taghian AG, "Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy : results from five national surgical adjuvant breast and bowel project randomized clinical trials", J Clin Oncol, 24, pp.3927~3932 (2006)
- Floyd SR, "Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger", Int J Radiat Oncol Biol Phys, 66, pp.358~364 (2006)
- Recht A, "Postmastectomy radiotherapy : an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update", J Clin Oncol, 34, pp.4431~4442 (2016)
- Poortmans PM, "Internal mammary and medial supraclavicular irradiation in breast cancer", N Engl J Med, 373, pp.317~327 (2015)
- Whelan TJ, "Regional nodal irradiation in early-stage breast cancer", N Engl J Med, 373, pp.307~316 (2015)
- Goulart J, "Outcomes of node-negative breast cancer 5 centimeters and larger treated with and without postmastectomy radiotherapy", Int J Radiat Oncol Biol Phys, 80, pp.758~764 (2011)
- Wenz F, "DEGRO practical guidelines for radiotherapy of breast cancer IV : radiotherapy following mastectomy for invasive breast cancer", Strahlenther Onkol, 190, pp.705~714 (2014)
- Forissier V, "Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohort", Eur J Cancer, 87, pp.47~57 (2017)
- Cassidy RJ, "The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer", Cancer, 123, pp.2829~2839 (2017)
- Velikova G, "Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer(SUPREMO) : 2-year follow-up results of a randomised controlled trial", Lancet Oncol, 19, pp.1516~1529 (2018)